News
What Is Dyskinesia? Symptoms, Causes and Treatment
If you’ve watched TV lately, you’ve seen a wave of ads about... Here goes the content ...
AI models using clinical and biomarker data identified Parkinson’s patients at risk for rapid cognitive or motor decline years in advance. Bascom Palmer researchers are studying cerebral visual impairment (CVI) to improve diagnosis through vision testing, imaging and genetics. A Miller School clinical trial is testing testosterone therapy in men with low-risk prostate cancer who are undergoing active surveillance. Latha Chandran leaves a lasting Miller School legacy through NextGenMD, faculty development and transformative medical education leadership.
Can AI Models Identify Parkinson’s Patients at Risk for Faster Decline?
Seeing Beyond the Eyes: Bascom Palmer Eye Institute Researchers Advance Understanding of Cerebral Visual Impairment
Miller School Trial Tests Testosterone Therapy in Men With Low-Risk Prostate Cancer
A Legacy of Transforming Medical Education: Dr. Latha Chandran Retires from the Miller School of Medicine
